Cutler Group LP Verona Pharma PLC Put Options Transaction History

Cutler Group LP

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Jan 18, 2024	BUY	$11.94 - $20.47 $5,970 - $10,235	500 Added 100.0%	1,000 $0
Q3 2023 Nov 07, 2023	BUY	$16.3 - $22.09 $8,150 - $11,045	500 New	500 $1,000
Q1 2023 May 01, 2023	SELL	$18.06 - $25.27 $305,214 - $427,063	-16,900 Reduced 98.26%	300 $0
Q4 2022 Feb 07, 2023	BUY	$9.84 - $26.13 $169,248 - $449,436	17,200 New	17,200 $3,000

167

68.7M

704K

685K

Ticker VRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,954,200
Market Cap $2.54B
Description
Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.